Literature DB >> 21633373

FLI1 polymorphism affects susceptibility to cutaneous leishmaniasis in Brazil.

L Castellucci1, S E Jamieson, E N Miller, L F de Almeida, J Oliveira, A Magalhães, L H Guimarães, M Lessa, E Lago, A R de Jesus, E M Carvalho, J M Blackwell.   

Abstract

Mapping murine genes controlling cutaneous leishmaniasis (CL) identified Fli1 as a candidate influencing resistance to L. major and enhanced wound healing. We examine FLI1 as a gene controlling CL and mucosal leishmaniasis (ML) caused by L. braziliensis in humans. Intron 1 single nucleotide polymorphisms tagging promoter and enhancer elements were analysed in 168 nuclear families (250 CL; 87 ML cases) and replicated in 157 families (402 CL; 39 ML cases). Robust case-pseudocontrol logistic regression analysis showed association between allele C (odds ratio (OR) 1.65; 95% confidence interval 1.18-2.29; P=0.003) of FLI1_rs7930515 and CL in the primary sample that was confirmed (OR 1.60; 95% confidence interval 1.10-2.33; P=0.014) in the replication set (combined P=1.8 × 10(-4)). FLI1_rs7930515 is in linkage disequilibrium with the functional GAn microsatellite in the proximal promoter. Haplotype associations extended across the enhancer, which was not polymorphic. ML associated with inverse haplotypes compared with CL. Wound healing is therefore important in CL, providing potential for therapies modulating FLI1.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21633373      PMCID: PMC3297968          DOI: 10.1038/gene.2011.37

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  35 in total

1.  A generalization of the transmission/disequilibrium test for uncertain-haplotype transmission.

Authors:  D Clayton
Journal:  Am J Hum Genet       Date:  1999-10       Impact factor: 11.025

Review 2.  The ETS-domain transcription factor family.

Authors:  A D Sharrocks
Journal:  Nat Rev Mol Cell Biol       Date:  2001-11       Impact factor: 94.444

3.  Evaluation of IFN-gamma and TNF-alpha as immunological markers of clinical outcome in cutaneous leishmaniasis.

Authors:  Argemiro D'Oliveira; Paulo Machado; Olívia Bacellar; Lay Har Cheng; Roque P Almeida; Edgar M Carvalho
Journal:  Rev Soc Bras Med Trop       Date:  2002 Jan-Feb       Impact factor: 1.581

4.  Case/pseudocontrol analysis in genetic association studies: A unified framework for detection of genotype and haplotype associations, gene-gene and gene-environment interactions, and parent-of-origin effects.

Authors:  Heather J Cordell; Bryan J Barratt; David G Clayton
Journal:  Genet Epidemiol       Date:  2004-04       Impact factor: 2.135

5.  Serum levels of tumor necrosis factor in patients with American cutaneous leishmaniasis.

Authors:  M Castes; D Trujillo; M E Rojas; C T Fernandez; L Araya; M Cabrera; J Blackwell; J Convit
Journal:  Biol Res       Date:  1993       Impact factor: 5.612

6.  DNA-binding specificities of the GATA transcription factor family.

Authors:  L J Ko; J D Engel
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

Review 7.  Mucosal leishmaniasis ("espundia" Escomel, 1911).

Authors:  P D Marsden
Journal:  Trans R Soc Trop Med Hyg       Date:  1986       Impact factor: 2.184

8.  Up-regulation of Th1-type responses in mucosal leishmaniasis patients.

Authors:  Olívia Bacellar; Hélio Lessa; Albert Schriefer; Paulo Machado; Amélia Ribeiro de Jesus; Walderez O Dutra; Kenneth J Gollob; Edgar M Carvalho
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

9.  A GA microsatellite in the Fli1 promoter modulates gene expression and is associated with systemic lupus erythematosus patients without nephritis.

Authors:  Erin E Morris; May Y Amria; Emily Kistner-Griffin; John L Svenson; Diane L Kamen; Gary S Gilkeson; Tamara K Nowling
Journal:  Arthritis Res Ther       Date:  2010-11-18       Impact factor: 5.156

10.  Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis.

Authors:  M Cabrera; M A Shaw; C Sharples; H Williams; M Castes; J Convit; J M Blackwell
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

View more
  16 in total

1.  The Abl and Arg kinases mediate distinct modes of phagocytosis and are required for maximal Leishmania infection.

Authors:  Dawn M Wetzel; Diane McMahon-Pratt; Anthony J Koleske
Journal:  Mol Cell Biol       Date:  2012-06-04       Impact factor: 4.272

2.  Wound healing genes and susceptibility to cutaneous leishmaniasis in Brazil: role of COL1A1.

Authors:  Lucas Almeida; Joyce Oliveira; Luiz Henrique Guimarães; Edgar M Carvalho; Jenefer M Blackwell; Léa Castellucci
Journal:  Infect Genet Evol       Date:  2015-01-03       Impact factor: 3.342

Review 3.  The immunological, environmental, and phylogenetic perpetrators of metastatic leishmaniasis.

Authors:  Mary-Anne Hartley; Stefan Drexler; Catherine Ronet; Stephen M Beverley; Nicolas Fasel
Journal:  Trends Parasitol       Date:  2014-06-20

4.  Fine mapping under linkage peaks for symptomatic or asymptomatic outcomes of Leishmania infantum infection in Brazil.

Authors:  Jason L Weirather; Priya Duggal; Eliana L Nascimento; Gloria R Monteiro; Daniella R Martins; Henio G Lacerda; Michaela Fakiola; Jenefer M Blackwell; Selma M B Jeronimo; Mary E Wilson
Journal:  Infect Genet Evol       Date:  2016-05-04       Impact factor: 3.342

5.  Genetic variant strains of Leishmania (Viannia) braziliensis exhibit distinct biological behaviors.

Authors:  Felipe Dutra Rêgo; Ana Cristina Vianna Mariano da Rocha Lima; Agnes Antônia Sampaio Pereira; Patrícia Flávia Quaresma; Marcelo Antônio Pascoal-Xavier; Jeffrey Jon Shaw; Célia Maria Ferreira Gontijo
Journal:  Parasitol Res       Date:  2018-07-18       Impact factor: 2.289

6.  Wound healing genes and susceptibility to cutaneous leishmaniasis in Brazil.

Authors:  Léa Castellucci; Sarra E Jamieson; Lucas Almeida; Joyce Oliveira; Luiz Henrique Guimarães; Marcus Lessa; Michaela Fakiola; Amélia Ribeiro de Jesus; E Nancy Miller; Edgar M Carvalho; Jenefer M Blackwell
Journal:  Infect Genet Evol       Date:  2012-03-28       Impact factor: 3.342

7.  Comprehensive candidate gene analysis for symptomatic or asymptomatic outcomes of Leishmania infantum infection in Brazil.

Authors:  Jason L Weirather; Priya Duggal; Eliana L Nascimento; Gloria R Monteiro; Daniella R Martins; Henio G Lacerda; Michaela Fakiola; Jenefer M Blackwell; Selma M B Jeronimo; Mary E Wilson
Journal:  Ann Hum Genet       Date:  2017-01-04       Impact factor: 1.670

8.  Analysis of expression of FLI1 and MMP1 in American cutaneous leishmaniasis caused by Leishmania braziliensis infection.

Authors:  Jenefer M Blackwell; Léa C Castellucci; Lucas Almeida; Juliana A Silva; Viviane M Andrade; Paulo Machado; Sarra E Jamieson; Edgar M Carvalho
Journal:  Infect Genet Evol       Date:  2017-01-21       Impact factor: 3.342

9.  Combined Strategies to Improve the Expression of Recombinant Sterol C24-Methyltransferase from Leishmania braziliensis in E. coli.

Authors:  Humberto F Freitas; Acássia Benjamim Leal Pires; Marcelo S Castilho
Journal:  Mol Biotechnol       Date:  2018-04       Impact factor: 2.695

10.  A Genome-wide Association Study Identifies SERPINB10, CRLF3, STX7, LAMP3, IFNG-AS1, and KRT80 As Risk Loci Contributing to Cutaneous Leishmaniasis in Brazil.

Authors:  Léa C Castellucci; Lucas Almeida; Svetlana Cherlin; Michaela Fakiola; Richard W Francis; Edgar M Carvalho; Anadílton Santos da Hora; Tainã Souza do Lago; Amanda B Figueiredo; Clara M Cavalcanti; Natalia S Alves; Katia L P Morais; Andréa Teixeira-Carvalho; Walderez O Dutra; Kenneth J Gollob; Heather J Cordell; Jenefer M Blackwell
Journal:  Clin Infect Dis       Date:  2021-05-18       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.